GEORGE TOWN: A Malaysia-based biotech company is set to develop a vaccine in eight years for the EV71 virus, which causes the infectious and potentially fatal hand, foot and mouth disease (HFMD).
The company embarking on this ambitious task is Sentinext Therapeutics Sdn Bhd with its laboratory in Universiti Sains Malaysia (USM), Penang.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!